In lipid metabolism, dual inhibitors of fatty acid-binding protein 4 (FABP4) and FABP5 significantly ameliorate lipid metabolism disorders, reduce fatty acid oxidation and utilization, and indirectly affect lactate production [191]. Here, FABP4 is linked to Disorder of lipid metabolism.